‘alpha’ of scaled ABE? [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2013-03-15 18:27 (4056 d 13:15 ago) – Posting: # 10203
Views: 20,662

Dear Detlew!

❝ A rather natural choice IMHO would be to calculate the power at the border(s) of the widened BE acceptance limits.


Agree.

GMR=1.25 if CV<=0.3 or GMR=exp(0.8925742*CV2se(CV)) if CV>0.3 for the FDA RSABE

GMR=1.25 if CV<=0.3 or GMR=exp(0.7601283*CV2se(CV)) if CV>0.3 for the EMA scABEL and cap on if CV>0.5


<nitpicking>

I would prefer a GMR of 0.80 since PowerTOST employs simulations – remember the [msg]“rounding thread”[/msg]? ;-)

</nitpicking>

Which designs / sample sizes have you used? I’m struggling reproducing your numbers.

❝ Interesting! At least for me :yes:.


For me as well. I will ask the two Lászlós and maybe Panos Macheras.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,990 posts in 4,826 threads, 1,665 registered users;
62 visitors (0 registered, 62 guests [including 5 identified bots]).
Forum time: 08:42 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5